ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,203.91
0.25%
Dow Jones
38,441.54
-1.06%
Gold vs US Dollar
2,332.115
-0.28%
Brent Oil
83.045
-0.40%
Bitcoin
67,615.69
0.05%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Astrazeneca Plc (AZN)

  7. Astrazeneca Plc (AZN) News

Astrazeneca (AZN)

Astrazeneca Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:AZN
DateTimeSourceHeadlineSymbolCompany
29/05/202408:54Alliance NewsAlliance NewsIN BRIEF: AstraZeneca drug lowers cholesterol in phase 1 trialLSE:AZNAstrazeneca Plc
29/05/202408:54Alliance NewsAlliance NewsIN BRIEF: AstraZeneca drug lowers cholesterol in phase 1 trialLSE:AZNAstrazeneca Plc
28/05/202407:00RNS Regulatory NewsAstraZeneca PLC Dato-DXd improved OS in nonsquamous lung cancerLSE:AZNAstrazeneca Plc
27/05/202407:49Alliance NewsAlliance NewsIN BRIEF: Astra, Daiichi hail positive survival data for Dato-DXdLSE:AZNAstrazeneca Plc
27/05/202407:49Alliance NewsAlliance NewsIN BRIEF: Astra, Daiichi hail positive survival data for Dato-DXdLSE:AZNAstrazeneca Plc
21/05/202412:18Alliance NewsAlliance NewsEXTRA: AstraZeneca pins hopes on pipeline as plans new era of growthLSE:AZNAstrazeneca Plc
21/05/202412:18Alliance NewsAlliance NewsEXTRA: AstraZeneca pins hopes on pipeline as plans new era of growthLSE:AZNAstrazeneca Plc
21/05/202408:18Alliance NewsAlliance NewsTOP NEWS: AstraZeneca eyes new era of growth with bold new revenue aimLSE:AZNAstrazeneca Plc
21/05/202408:18Alliance NewsAlliance NewsTOP NEWS: AstraZeneca eyes new era of growth with bold new revenue aimLSE:AZNAstrazeneca Plc
21/05/202407:00RNS Regulatory NewsAstraZeneca PLC AstraZeneca to deliver $80bn revenue by 2030LSE:AZNAstrazeneca Plc
20/05/202408:24Alliance NewsAlliance NewsTOP NEWS: AstraZeneca plans to build manufacturing plant in SingaporeLSE:AZNAstrazeneca Plc
20/05/202408:24Alliance NewsAlliance NewsTOP NEWS: AstraZeneca plans to build manufacturing plant in SingaporeLSE:AZNAstrazeneca Plc
20/05/202407:00RNS Regulatory NewsAstraZeneca PLC AstraZeneca to manufacture ADCs in SingaporeLSE:AZNAstrazeneca Plc
16/05/202410:27Alliance NewsAlliance NewsAstraZeneca trials yield positive results for immunocompromised patientsLSE:AZNAstrazeneca Plc
16/05/202410:27Alliance NewsAlliance NewsAstraZeneca trials yield positive results for immunocompromised patientsLSE:AZNAstrazeneca Plc
16/05/202407:00RNS Regulatory NewsAstraZeneca PLC SUPERNOVA Trial Met COVID-19 prevention endpointLSE:AZNAstrazeneca Plc
15/05/202415:00RNS Regulatory NewsAstraZeneca PLC Director/PDMR ShareholdingLSE:AZNAstrazeneca Plc
08/05/202409:44Alliance NewsAlliance NewsAstraZeneca says withdraws Covid vaccine "for commercial reasons"LSE:AZNAstrazeneca Plc
08/05/202409:44Alliance NewsAlliance NewsAstraZeneca says withdraws Covid vaccine "for commercial reasons"LSE:AZNAstrazeneca Plc
07/05/202407:00RNS Regulatory NewsAstraZeneca PLC AstraZeneca completes Cellectis equity investmentLSE:AZNAstrazeneca Plc
06/05/202407:46Alliance NewsAlliance NewsAstraZeneca completes collaboration and investment deal with CellectisLSE:AZNAstrazeneca Plc
06/05/202407:46Alliance NewsAlliance NewsAstraZeneca completes collaboration and investment deal with CellectisLSE:AZNAstrazeneca Plc
02/05/202410:04Alliance NewsAlliance NewsAstraZeneca notes positive trial results for Calquence treatmentLSE:AZNAstrazeneca Plc
02/05/202410:04Alliance NewsAlliance NewsAstraZeneca notes positive trial results for Calquence treatmentLSE:AZNAstrazeneca Plc
02/05/202407:00RNS Regulatory NewsAstraZeneca PLC Calquence combination improved PFS in 1L MCLLSE:AZNAstrazeneca Plc
01/05/202415:00RNS Regulatory NewsAstraZeneca PLC Total Voting RightsLSE:AZNAstrazeneca Plc
29/04/202409:13Alliance NewsAlliance NewsAstraZeneca makes progress with Truqap and Enhertu cancer treatmentsLSE:AZNAstrazeneca Plc
29/04/202409:13Alliance NewsAlliance NewsAstraZeneca makes progress with Truqap and Enhertu cancer treatmentsLSE:AZNAstrazeneca Plc
29/04/202407:05RNS Regulatory NewsAstraZeneca PLC Truqap recommended for EU breast cancer approvalLSE:AZNAstrazeneca Plc
29/04/202407:00RNS Regulatory NewsAstraZeneca PLC Enhertu improved PFS in HER2-low and ultralowLSE:AZNAstrazeneca Plc
 Showing the most relevant articles for your search:LSE:AZN

Your Recent History

AQSE
CUSH
Crushmetric
LSE
0KX7
Severcoop Gamza Holding Ad
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved